Catalyst Wire Dossier Catalyst Wire Dossier

Oramed oral insulin

insulin (oral formulation) · Oramed Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oramed oral insulin, covering 2024-03-29 to 2024-03-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]

See pricing